Showing 7 posts of 7 posts found.


AZ licenses kidney drug from Ionis for $330m

February 21, 2018
Research and Development, Sales and Marketing AstraZeneca, Ionis, Isis, biotech, drugs, kidney, pharma, pharmaceutical

AstraZeneca continues to build on its relationship with San Diego-based Ionis Pharmaceuticals, this time by agreeing a licensing deal for …


Keryx Biopharmaceuticals announces positive Phase III study results for anaemia treatment

March 30, 2016
Research and Development CKD, anaemia, chronic kidney disease, clinical trial, dialysis, keryx, keryx biopharmaceuticals, kidney, phase 3, phase III

Keryx Biopharmaceuticals (NASDAQ: KERX) has announced positive top-line results for its Phase III study of ferric citrate for the treatment …

QELFA device

Novel device could help fight kidney disease

February 24, 2015
Research and Development, Sales and Marketing Bio Nano Consulting, Pfizer, QELFA, Rapamune, device, ime, kidney

A novel device that combines nanotechnology and a pregnancy tester could help treat kidney disease, according to a report by …

Merck Serono image

Research pact joins Pfizer and Merck Serono with academics

April 3, 2014
Research and Development, Sales and Marketing Lupus, Merck Serono, Pfizer, broad institute, emd, kidney

Merck’s US affiliate EMD Serono and Pfizer have entered into a research agreement with the Broad Institute to investigate autoimmune …

Novartis image

Novartis signs Regenerex deal

September 9, 2013
Sales and Marketing CLL, Novartis, kidney, regenerex

Novartis has signed a deal with US biopharma firm Regenerex to use its novel stem cell-based platform, which may have …

astrazeneca image

AstraZeneca signs $350m kidney deal

August 1, 2013
Sales and Marketing AstraZeneca, CKD, fibrogen, kidney

AstraZeneca has signed a deal with private biotech company FibroGen to develop a novel compound aimed at treating anaemia associated …

Abbott pulls kidney disease trial

October 22, 2012
Research and Development, Sales and Marketing Abbott, Reata, kidney

Abbott has terminated its Phase III trial of bardoxolone methyl in patients with kidney disease and diabetes after concerns over …

Latest content